Reports and presentations

2025

• Financial statement 2024 (14.2.2025)

• Financial statement bulletin 2024 (14.2.2025)

2024

• 2024-Q3 business review presentation (14.11.2024) 

• Business review January – September 2024 (14.11.2024)

• Investor presentation (4.10.2024)

• Half-year report January-June 2024 (15.8.2024)

• Business review January–March 2024 (16.5.2024)

• Annual Report 2023 (15.3.2024)

• Financial statement 2023 (15.3.2024)

• Danske Bank – Small Cap Day (14.3.2024)
  | Slides |

• Financial statement bulletin 2023 (16.2.2024)

2023

• Danske Bank – Small Cap Day (3.10.2023)
  | Slides |

• Half Year Report H1-2023 (11.8.2023)

• Live event for investors and media about RemeOs™ FDA approval (30.3.2023)
   | Video | Slides |

• Annual Report 2022 (17.3.2023)

• Financial statement 2022 (17.3.2023)

• CEO Timo Lehtonen's interview on Inderes (17.2.2023)

• Financial statement bulletin 2022 (17.2.2023)

2022

• On Dec 13, 2022  Bioretec participated in Health Technology and Pharmaceutical Developer Night organized by Inderes
   Presentation material (pdf)

• Half Year report 2022 (12.8.2022)

• Bioretec Company Presentation 05/2022

• CEO Timo Lehtonen's presentation at the Inderes invertor day (23.5.2022)

  • Presentation material

• Annual Report 2021 (11.3.2022)

• Financial statements 2021 (11.3.2022)

• Financial statements bulletin 2021 (17.2.2022)